Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Journal of Hematology & Oncology|April 20, 2018
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3aMan-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
World Journal of Pediatrics : WJP|December 2, 2025
A new era in CAR-NK cell therapy: from technological innovations to clinical applicationsQing Ye, Wen-Xuan Li, Ming-Yu Lai, et al.
Chinese Medical Journal|November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative ResectionHui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.
Liver Cancer|January 14, 2021
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Liver Cancer|October 30, 2023
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Liver Cancer|October 9, 2025
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Pageof 23